Neuropace Stock Price on May 8, 2025

NPCE Stock  USD 8.99  0.48  5.64%   
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neuropace stands at 8.99, as last reported on the 4th of August, with the highest price reaching 9.06 and the lowest price hitting 8.25 during the day. Neuropace has Sharpe Ratio of -0.0482, which conveys that the firm had a -0.0482 % return per unit of risk over the last 3 months. Neuropace exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuropace's Mean Deviation of 3.04, risk adjusted performance of (0.03), and Standard Deviation of 5.41 to check out the risk estimate we provide.
Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Neuropace Valuation on May 8, 2025

It is possible to determine the worth of Neuropace on a given historical date. On May 8, 2025 Neuropace was worth 12.31 at the beginning of the trading date compared to the closed value of 12.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neuropace stock. Still, in general, we apply an absolute valuation method to find Neuropace's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuropace where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neuropace's related companies.
 Open High Low Close Volume
  11.82    12.24    11.56    12.12    103,005  
05/08/2025
  12.31    12.91    11.88    12.55    155,293  
  12.60    13.19    12.52    12.89    188,035  
Backtest Neuropace  |  Neuropace History  |  Neuropace Valuation   PreviousNext  
Open Value
12.31
12.55
Closing Value
28.55
Upside

Neuropace Trading Date Momentum on May 8, 2025

On May 09 2025 Neuropace was traded for  12.89  at the closing time. The top price for the day was 13.19  and the lowest listed price was  12.52 . The trading volume for the day was 188 K. The trading history from May 9, 2025 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.71% . The trading delta at closing time against the current closing price is 36.25% .

Neuropace Fundamentals Correlations and Trends

By evaluating Neuropace's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neuropace's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neuropace financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Neuropace Stock history

Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
NeuroPace, Inc. operates as a medical device company in the United States. The company was incorporated in 1997 and is headquartered in Mountain View, California. Neuropace operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 187 people.

Neuropace Stock Technical Analysis

Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neuropace technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neuropace trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neuropace Period Price Range

Low
August 4, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Neuropace cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Neuropace August 4, 2025 Market Strength

Market strength indicators help investors to evaluate how Neuropace stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuropace shares will generate the highest return on investment. By undertsting and applying Neuropace stock market strength indicators, traders can identify Neuropace entry and exit signals to maximize returns

Neuropace Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Neuropace Stock analysis

When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios